Latest News & Features
Europe
The Paris Local Division says Merz ran out of time to stop Viatris' multiple sclerosis generic, clarifying the court’s urgency standards in the process. 1 December 2025
Europe
Joining an expanding IP litigation practice, the new partner adds experience in patent, SPC and multi-jurisdictional disputes across pharma, technology, and medical devices. 1 December 2025
Europe
The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step. 27 November 2025
Americas
Director Squires rescinds previous guidelines and clarifies that there is no separate, modified inventorship standard for AI-assisted inventions. 27 November 2025
Europe
Even when legal teams do include women, the judges say they don’t always see or hear them, emphasising that visibility is critical for aspiring advocates. 27 November 2025
Americas
Balancing tight budgets while keeping up with fast-changing biosimilar rules is all in a day’s work for Novartis’s R&D IP team, but how do they stay on top of it all? 26 November 2025
Europe
Regeneron and Bayer suffered a UK setback as the court followed others in Europe in its interpretation of the so-called SPC manufacturing waiver. 25 November 2025
Careers
A regulatory counsel with nine years at the FDA and over two decades of patent experience has joined a firm in Washington, DC. 24 November 2025
Europe
AI content in new enquiries is a growing problem, says the man leading the UK association’s AI Committee. Sarah Speight reports. 24 November 2025
Europe
The week exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector. 21 November 2025